Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) must be stored in a refrigerator at 2–8°C, kept away from the freezer compartment and direct light. Each KwikPen can also be kept at room temperature for a limited period once removed from the fridge — the exact window is printed in the Patient Information Leaflet, and following it precisely protects the medicine's effectiveness. Storing tirzepatide incorrectly can degrade the active ingredient without any visible sign that something is wrong. These are prescription-only medicines, so your prescriber and the leaflet inside your pack are the definitive guides for your specific situation.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Your Mounjaro KwikPen arrives in plain, unbranded packaging via tracked next-working-day delivery. Open the box promptly and transfer the pen to your fridge. The target temperature is 2–8°C, the middle shelf of a household fridge is usually reliable; the door is subject to more temperature swings, and the drawer nearest the freezer compartment can dip below freezing. A frozen pen is an unusable pen, so placement matters more than most people initially appreciate.
Keep the pen in its original carton inside the fridge. The cardboard shields it from the fridge light and from being knocked. Leave the pen cap on and the needle untouched until you are ready to inject. If your pen arrives on a warm day and has been in transit (this happens, particularly with summer orders or bank-holiday delays) feel the pen casing: it should be cool, not warm. If you have any doubt about whether it has been stored correctly in transit, contact our support team before using it.
One practical note: if your delivery falls on a Friday before a bank holiday, plan ahead. For a full breakdown of placement, temperature limits and what to do after opening, our guide to storing Mounjaro after first use covers every stage in detail.
Tirzepatide, like other biological medicines, can tolerate time outside the fridge) but only up to the limit stated in the Patient Information Leaflet. That limit exists because the molecule degrades at higher temperatures, and unlike a spoiled yoghurt, a degraded pen gives no visible warning. The liquid will still look clear.
The leaflet specifies the maximum number of days and the maximum temperature for out-of-fridge storage. Do not rely on memory or online forums for this figure; open the leaflet that came with your pen. Once the room-temperature window has elapsed, the pen should not be used even if it has been kept cool.
This matters most for travel (a topic covered in detail in the Mounjaro FAQs) and for workplaces or situations where access to a fridge is intermittent. Plan the room-temperature clock from the moment the pen leaves the fridge, not from when you first open the box.
Before each weekly dose, inspect the pen. The solution should be clear to slightly opalescent (a faint pearlescent quality is normal) and essentially colourless to pale yellow. Visible particles, cloudiness beyond that slight natural quality, or discolouration are reasons not to use the pen. Equally, a pen that has been dropped hard onto a hard floor may have a damaged mechanism even if it looks intact externally.
For a fuller picture of what to monitor during treatment (including weight, blood pressure and blood tests) the Mounjaro monitoring guide covers what a prescriber typically tracks alongside therapy. That context is worth understanding before you start, not just when something seems off.
If you are unsure whether a pen is still usable, the safest answer is to contact your prescriber rather than proceed. A wasted pen is a minor inconvenience; a degraded dose means a week of treatment that does not work as intended.
Used pens and needles are clinical waste. Do not put them in your household bin or recycling. A dedicated sharps container is the correct disposal method; local pharmacies and GP surgeries often accept full containers for safe disposal. Keeping needles capped and pens in the original carton until disposal also reduces the risk of accidental needlestick injury for anyone handling your rubbish.
If you want to understand more about tirzepatide itself (how it works, the clinical evidence behind it, and whether it might be appropriate for you) the tirzepatide overview and the Mounjaro treatment page cover both in plain language. The cost side of private treatment is addressed on the Eli Lilly price increase page, which explains how UK list prices have changed and what that means for private patients. Storage questions often come up alongside general queries about starting treatment, so the free consultation page is there when you are ready to take the next step, a real prescriber reviews every application, not an automated system. If you would like to hear how others have found the process, our Mounjaro stories page shares real patient experiences from people at different stages of treatment.
The NHS tirzepatide medicines page also carries patient-level storage guidance you can cross-reference at any time.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.